In a study published by Vijenthira et al in JNCCN–Journal of the National Comprehensive Cancer Network, a research team sought to determine frailty is associated with survival in a population-based sample of patients with diffuse large B-cell lymphoma (DLBCL) and to describe the difference in health-care utilization between frail and nonfrail patients (if one was discovered).
